DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Becaplermin
Becaplermin
Biomaterials: a Potential Pathway to Healing Chronic Wounds?
2021 Formulary List of Covered Prescription Drugs
Access Tier 4 PPO Prescription Drug List CDI Version
Becaplermin (Regranex) Reference Number: ERX.NPA.31 Effective Date: 07.01.15 Last Review Date: 02.21 Line of Business: Commercial, Medicaid Revision Log
Products Containing Butalbital Intravenous Antibiotics for Treatment of MRSA And
Becaplermin) Outcome of a Procedure Under Article 20 of Regulation (EC) No 726/2004
Ibm Micromedex® Carenotes Titles by Category
INN Working Document 05.179 Update December 2010
REGRANEX® (Becaplermin) Gel
(INN) for Biological and Biotechnological Substances
Large Group Tier 4 HMO and PPO Prescription Drug List DMHC Version
Regranex, INN-Becaplermin
MTUS DRUG-LIST-V3-Addendum-One-Effective 10012018
Diabetic Foot Ulcer Market in Need of Healing
Lower Extremity Major and Minor Amputations in the High Risk Patient
Who Expert Committee on Specifications for Pharmaceutical Preparations
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
2021 Aetna Standard Plan
Top View
2021 California Advantage Large Group 3-Tier HMO and PPO Prescription Drug List
FEP 5 Tier Rx Drug Formulary (607) Standard Option
Long-Term Care Drug Database System: Drugs by NDC Class Code, Drug Code and Name
Medicines Regulations 1984 (SR 1984/143)
Growth Factors for Treating Diabetic Foot Ulcers (Review)
Regranex Label
Physician-Initiated Clinical Study of Limb Ulcers Treated with a Functional Peptide, SR-0379: from Discovery to a Randomized, Double-Blind, Placebo-Controlled Trial
Drug Coverage Guidelines – Oxford Clinical Policy
(PA) Cross Reference
Effects of Topical Application of CHF6467, a Mutated Form of Human Nerve Growth Factor, on Skin Wound Healing in Diabetic Mice
September 2021 California Advantage Large Group 3-Tier PPO Prescription Drug List – CDI Version
Cutaneous Wound Healing: an Update from Physiopathology to Current Therapies
Becaplermin Gel (Regranex®)
Oregon Medicaid Fee-For-Service
Becaplermin Gel in the Treatment of Diabetic Neuropathic Foot Ulcers
WO 2014/165513 A2 9 October 2014 (09.10.2014) P O P C T
Recombinant and Autologous Platelet Derived Growth Factors As Tx of Wound Healing and Other Non-Orthopedic Conditions
Regranex) Reference Number: CP.PMN.21 Effective Date: 09.01.06 Last Review Date: 02.21 Line of Business: Medicaid Revision Log
AHFS Pharmacologic-Therapeutic Classification System
FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
Diabetic Foot Ulcers - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update
Regranex) Reference Number: ERX.NPA.31 Effective Date: 06.01.15 Last Review Date: 08.17 Line of Business: Commercial [Prescription Drug Plan] Revision Log
Oregon Medicaid Fee-For-Service
PA Drug Name Generic Name PA Summary Name Epaned Enalapril
Prescription Drug List
Mai Mult a Tinktu U U Utotoni Miui
Regranex, INN-Becaplermin
MTUS Drug List V8 (Addendum One)
Research Agenda for Health Economic Evaluation
2021 California Access Large Group 3-Tier PPO Prescription Drug List
UMP (Wsrxs) Preferred Drug List (PDL) 2021
Apple Health "Medicaid" Preferred Drug List Effective January 1, 2020 the Apple Health Preferred Drug List (PDL) Has Products Listed in Groups by Drug Class
Role of Platelet-Derived Growth Factors in Physiology and Medicine